Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-22.41M
↑ 30% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-31.93M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-22.41M | +62.7% |
| 2024 | $-60.04M | +27.1% |
| 2023 | $-82.31M | -573.2% |
| 2022 | $-12.23M | +68.8% |
| 2021 | $-39.20M | -42.8% |
| 2020 | $-27.45M | +27.1% |
| 2019 | $-37.66M | -64.9% |
| 2018 | $-22.83M | -28.5% |
| 2017 | $-17.77M | -777.5% |
| 2016 | $2.62M | - |